Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections – SMART United States 2018–2019

by James A. Karlowsky, Sibylle H. Lob, Katherine Young, Mary R. Motyl, Daniel F. Sahm
Published 2021-03-01

Activity of ceftolozane–tazobactam and comparators against Pseudomonas aeruginosa from patients in different risk strata – SMART United States 2016–2017

by Sibylle H. Lob, Daryl J. Hoban, Katherine Young, Mary R. Motyl, Daniel F. Sahm
Published 2020-03-01

In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples: SMART Surveillance...

by James A. Karlowsky, Sibylle H. Lob, Krystyna M. Kazmierczak, Katherine Young, Mary R. Motyl, Daniel F. Sahm
Published 2020-06-01

In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa

by Katherine Young, Ronald E. Painter, Susan L. Raghoobar, Nichelle N. Hairston, Fred Racine, Douglas Wisniewski, Carl J. Balibar, Artjohn Villafania, Rumin Zhang, Daniel F. Sahm, Timothy Blizzard, Nicholas Murgolo, Milton L. Hammond, Mary R. Motyl
Published 2019-07-01